Jennifer Champoux

Companies

• Monte Rosa TherapeuticsChief operating officer Jun 5, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MRMonte Rosa Therapeutics GLUE62,371 shares²$663.0K at $10.63Jul 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 15, 2026Sold 4,351 shares at $23.38 of Monte Rosa Therapeutics²
• Jul 15, 2026Exercised options 4,351 shares at $3.98 of Monte Rosa Therapeutics²
• Jun 23, 2026Sold 2,175 shares at $20.00 of Monte Rosa Therapeutics³
• Jun 23, 2026Exercised options 2,175 shares at $3.98 of Monte Rosa Therapeutics³
• Jun 17, 2026Sold 2,176 shares at $19.00 of Monte Rosa Therapeutics⁴
• Jun 17, 2026Exercised options 2,176 shares at $3.98 of Monte Rosa Therapeutics⁴
• May 27, 2026Sold 2,175 shares at $20.00 of Monte Rosa Therapeutics⁵
• May 27, 2026Exercised options 2,175 shares at $3.98 of Monte Rosa Therapeutics⁵
• May 22, 2026Sold 2,176 shares at $19.00 of Monte Rosa Therapeutics⁶
• May 22, 2026Exercised options 2,176 shares at $3.98 of Monte Rosa Therapeutics⁶
• Jan 5, 2026Sold 2,629 shares at $15.17 of Monte Rosa Therapeutics⁷
• Jan 2, 2026Granted 35,000 shares of Monte Rosa Therapeutics⁷
• Jan 2, 2025Granted 30,000 shares of Monte Rosa Therapeutics⁸